ROCK SPRINGS CAPITAL MANAGEMENT LP BioCryst Pharmaceuticals, Inc. Transaction History

ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:

$21.57M
portfolio value

ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +17.21% 251.41K shares 6.12M $12.6 1.71M
Q2 2022 share Increase 0.00% 1.46M shares 15.45M $10.58 1.46M
Q2 2019 share Decrease -100.00% -700K shares -5.69M $3.79 0
Q1 2019 share 0.00% 0 shares 49K $8.14 700K
Q4 2018 share 0.00% 0 shares 308K $8.07 700K
Q3 2018 share Increase +180.00% 450K shares 3.90M $7.63 700K
Q2 2018 share Decrease -72.97% -675K shares -2.97M $5.73 250K
Q1 2018 share Increase +13.85% 112.5K shares 423K $4.77 925K
Q4 2017 share Increase +80.56% 362.5K shares 1.63M $4.91 812.5K
Q3 2017 share Increase 0.00% 450K shares 2.35M $5.24 450K